New possibilities of pharmacotherapy for chronic obstructive pulmonary disease
The use of bronchodilators (DB) remains up to the present day the leading therapeutic strategy for the treatment of chronic obstructive pulmonary disease (COPD), in which case administration of fixed-dose combinations of long-acting bronchodilators seem the most promising. At the same time, the issu...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Remedium Group LLC
2018-10-01
|
| Series: | Медицинский совет |
| Subjects: | |
| Online Access: | https://www.med-sovet.pro/jour/article/view/2668 |
| _version_ | 1827961893744017408 |
|---|---|
| author | A. I. Sinopalnikov A. G. Romanovskikh Yu. G. Belotserkovskaya |
| author_facet | A. I. Sinopalnikov A. G. Romanovskikh Yu. G. Belotserkovskaya |
| author_sort | A. I. Sinopalnikov |
| collection | DOAJ |
| description | The use of bronchodilators (DB) remains up to the present day the leading therapeutic strategy for the treatment of chronic obstructive pulmonary disease (COPD), in which case administration of fixed-dose combinations of long-acting bronchodilators seem the most promising. At the same time, the issues of anti-inflammatory therapy of COPD are also actively discussed, first of which is feasibility for the wide use of fixed-dose combinations of inhaled glucocorticosteroids (IHGC) with long-acting β2-agonists (LABA). Recent years are characterized by the launch of a significant number of new BDs, anti-inflammatory drugs and their combinations to the pharmaceutical market. The article considers the role and place of new drugs in the treatment of COPD having a stable course. |
| first_indexed | 2024-04-09T16:34:03Z |
| format | Article |
| id | doaj.art-140e0c417ea34ad1bdf491095b1cc0d6 |
| institution | Directory Open Access Journal |
| issn | 2079-701X 2658-5790 |
| language | Russian |
| last_indexed | 2024-04-09T16:34:03Z |
| publishDate | 2018-10-01 |
| publisher | Remedium Group LLC |
| record_format | Article |
| series | Медицинский совет |
| spelling | doaj.art-140e0c417ea34ad1bdf491095b1cc0d62023-04-23T06:56:59ZrusRemedium Group LLCМедицинский совет2079-701X2658-57902018-10-01015283710.21518/2079-701X-2018-15-28-372620New possibilities of pharmacotherapy for chronic obstructive pulmonary diseaseA. I. Sinopalnikov0A. G. Romanovskikh1Yu. G. Belotserkovskaya2Russian Medical Academy of Continuing Postgraduate Education of the Ministry of Health of RussiaRussian Medical Academy of Continuing Postgraduate Education of the Ministry of Health of RussiaRussian Medical Academy of Continuing Postgraduate Education of the Ministry of Health of RussiaThe use of bronchodilators (DB) remains up to the present day the leading therapeutic strategy for the treatment of chronic obstructive pulmonary disease (COPD), in which case administration of fixed-dose combinations of long-acting bronchodilators seem the most promising. At the same time, the issues of anti-inflammatory therapy of COPD are also actively discussed, first of which is feasibility for the wide use of fixed-dose combinations of inhaled glucocorticosteroids (IHGC) with long-acting β2-agonists (LABA). Recent years are characterized by the launch of a significant number of new BDs, anti-inflammatory drugs and their combinations to the pharmaceutical market. The article considers the role and place of new drugs in the treatment of COPD having a stable course.https://www.med-sovet.pro/jour/article/view/2668chronic obstructive pulmonary diseasepharmacotherapyvilenterol/umeclidiniumvilantherol / fluticasone furoate |
| spellingShingle | A. I. Sinopalnikov A. G. Romanovskikh Yu. G. Belotserkovskaya New possibilities of pharmacotherapy for chronic obstructive pulmonary disease Медицинский совет chronic obstructive pulmonary disease pharmacotherapy vilenterol/umeclidinium vilantherol / fluticasone furoate |
| title | New possibilities of pharmacotherapy for chronic obstructive pulmonary disease |
| title_full | New possibilities of pharmacotherapy for chronic obstructive pulmonary disease |
| title_fullStr | New possibilities of pharmacotherapy for chronic obstructive pulmonary disease |
| title_full_unstemmed | New possibilities of pharmacotherapy for chronic obstructive pulmonary disease |
| title_short | New possibilities of pharmacotherapy for chronic obstructive pulmonary disease |
| title_sort | new possibilities of pharmacotherapy for chronic obstructive pulmonary disease |
| topic | chronic obstructive pulmonary disease pharmacotherapy vilenterol/umeclidinium vilantherol / fluticasone furoate |
| url | https://www.med-sovet.pro/jour/article/view/2668 |
| work_keys_str_mv | AT aisinopalnikov newpossibilitiesofpharmacotherapyforchronicobstructivepulmonarydisease AT agromanovskikh newpossibilitiesofpharmacotherapyforchronicobstructivepulmonarydisease AT yugbelotserkovskaya newpossibilitiesofpharmacotherapyforchronicobstructivepulmonarydisease |